Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of K0706 in Subjects With Early Parkinson's Disease

Trial Profile

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of K0706 in Subjects With Early Parkinson's Disease

Status: Recruiting
Phase of Trial: Phase II

Latest Information Update: 23 Oct 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs SUN K706 (Primary)
  • Indications Parkinson's disease
  • Focus Therapeutic Use
  • Acronyms PROSEEK
  • Sponsors Sun Pharma Advanced Research Company
  • Most Recent Events

    • 10 Sep 2019 According to a CereScan media release, CereHealth, through its CereScan clinic in Littleton, CO, will provide scans of the participants' brains using DaT SPECT, an imaging tool that shows the density of healthy dopamine neurons.
    • 10 Sep 2019 According to a CereScan media release, CereHealth Corporation through its subsidiary CereScan has received approval of its Littleton, CO location as a qualified imaging facility for this phase 2 trial.
    • 13 Feb 2019 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top